Hualan Vac(SZ:301207) Sou Hu Cai Jing·2025-09-12 02:32Group 1 - The core point of the news is that Hualan Vaccine (301207) has seen a net financing purchase of 206.26 million yuan on September 11, 2025, with a financing balance of 1.19 billion yuan, indicating a positive trend in investor sentiment [1][4]. - Over the past three trading days, Hualan Vaccine has recorded a cumulative net purchase of 507.96 million yuan, with 11 out of the last 20 trading days showing net financing purchases [1][4]. - The financing balance increased by 1.76% compared to the previous day, reflecting a growing interest in the stock [4]. Group 2 - On September 11, 2025, there was a net short selling of 100 shares, with a total short selling balance of 2.44 million shares [3]. - In the last 20 trading days, there have been 12 days of net short selling, indicating a bearish sentiment among some investors [3]. - The total short selling balance on September 11 was valued at 45.84 million yuan [3]. Group 3 - The financing and securities lending balance reached 1.20 billion yuan on September 11, 2025, showing a significant increase in trading activity [4]. - The financing balance on September 10 was 1.18 billion yuan, which had increased from 1.16 billion yuan on September 9 [4]. - The fluctuations in the financing balance over the past few days indicate varying investor confidence in Hualan Vaccine [4].